Lenalidomide-TL - analogs
Components: Lenalidomide |
|||||||||
Pharmgroups: Other antitumor agents |
|||||||||
| Prices in pharmacies: — Instructions Lenalidomide-TL | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Epinephrine ✘ (incl) Halothane ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | neutral Revlimid | 1328€ |
| ≈100% | neutral Lenalidomide | — |
| ≈100% | neutral Lenalidomide-KRKA | — |
| ≈100% | neutral Lenalidomide Canon | — |
| ≈100% | neutral Lenalidomide-nativ | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 33% 194.3-777.1€ Darzalex neutral [Daratumumab]
- 30% — Иксазомиба цитрат neutral [Ixazomib]
- 29% — Милатиб neutral [Bortezomib]
- 29% — Бортезомиб Канон neutral [Bortezomib]
- 29% — Майборте neutral [Bortezomib]
- 29% 6352.5-6726.4€ Imnovid neutral [Pomalidomide]
- 29% — Pomalidomide-TL neutral [Pomalidomide]
- 29% 104.5€ Велмиб3.5 neutral [Bortezomib]
- 29% — Иматанго neutral [Pomalidomide]
- 28% — Oncofage neutral [Proteine]
- 27% 73.4€ Venclexta neutral [Venetoclax]
- 26% 140-149.4€ Velcade neutral [Bortezomib]
- 26% 2417.8€ Ninlaro neutral [Ixazomib]
- 26% — БОРАТЕРИН neutral [Bortezomib]
- 26% 788.9€ Kyprolis neutral [Carfilzomib]
- 26% — Verozomib neutral [Bortezomib]
- 26% — Bortezol neutral [Bortezomib]
- 26% 136.3€ Бартизар neutral [Bortezomib]
- 25% 2964.5€ Пикрэй neutral [Alpelisib]
- 25% 1381.2€ Empliciti neutral [Elotuzumab]
- 23% — Poglucar neutral
- 23% 204€ Fotoditazin neutral [Dimeglumine chlorin e6 and more 1Chlorine E6 dimeglumine Chlorin E6 dimeglumin]
- 22% 91.7€ Boramilan neutral [Bortezomib]
- 22% — Фаридак neutral [Panobinostat]
- 21% 15-21€ Цервикон -ДИМ neutral [Diindolylmethane]
- 21% — Factor tumor necrosis-thymosine alpha-1 recombinant neutral [Tumor necrosis factor-thymosine alpha-1 recombinant]
- 20% 992.7€ Talcenna neutral [Talazoparib]
- 20% — Помалидомид neutral [Pomalidomide]
- 20% — Androblok neutral [Bicalutamide]
- 20% 5.5-19.3€ Бикалутамид neutral [Bicalutamide]
- 19% — Бендамустин-ТЛ neutral [Bendamustine]
- 18% — Metvix neutral [Methylaminolevulinate]
- 18% 115€ Vidaza neutral [Azacitidine]
- 18% — Hexalen neutral [Altretamine]
- 18% — Miltex neutral [Miltefosine]
- 17% 11.6€ Anastrozole-Teva neutral [Anastrozole]
- 17% — Ferrum polyacrilate neutral [Ferric polyacrylate]
- 17% 10.4-14.1€ Arimidex neutral [Anastrozole]
- 17% — Anandron neutral [Nilutamide]
- 17% 5.7€ Selana neutral [Anastrozole]
- 17% 3112.5€ Erivedge neutral [Vismodegib]
- 17% — Feracryl neutral [Ferric polyacrylate]
- 17% — ГРАСТИГЕН neutral [Bendamustine]
- 17% — Анастрозол-тл neutral [Anastrozole]
- 17% 89-120.6€ Refnot neutral [Tumor necrosis factor-thymosine alpha-1 recombinant]
- 17% 118.3-133.5€ Glyciphon neutral [Diglycidyl methylphosphonate]
- 17% — Меркудиес neutral [Bendamustine]
- 17% — Бендамустин Канон neutral [Bendamustine]
- 17% — Anastera neutral [Anastrozole]
- 17% — Бендамустин-промомед neutral [Bendamustine]
Learn more about the selection of analogues
- The drug has «Lenalidomide-TL» 15 full analogs, the cheapest - Revlimid (1328€); 51 analog by action, the most similar - Darzalex (194.3-777.1€).
- Medical online service has selected the best substitutes for Lenalidomide-TL based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Lenalidomide-TL to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.